Critical review of prostate cancer predictive tools - Wikidata - awgldk - TriplyDB

Critical review of prostate cancer predictive tools

Critical review of prostate cancer predictive tools

http://www.wikidata.org/entity/Q34104562

about

Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer Modeling potential time to event data with competing risks.Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.Systematic review of clinical features of suspected prostate cancer in primary care.Improving prediction of prostate cancer recurrence using chemical imaging.Prognostic Utility of PET in Prostate Cancer.NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.Statistical consideration for clinical biomarker research in bladder cancer.Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.Novel concepts for risk stratification in prostate cancer.Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).Diagnostic and prognostic molecular biomarkers for prostate cancer.Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.Advances in oncologic imaging: update on 5 common cancers.Risk stratification in prostate cancer screening.Current, new and novel therapy for castration-resistant prostate cancer.Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Molecular alterations in prostate cancer and association with MRI features.Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort.Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.Prostate cancer biomarker: a key field to explore Plasma-seq: a novel strategy for metastatic prostate cancer analysis.Reply to association between exercise and primary incidence of prostate cancer: does race matter?Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.

P2860

Q28539777-0256720F-E12B-415E-9901-858562452BEA Q30669557-253BC5FB-8C0A-4427-B087-E4548B23A583 Q30975500-4B506CBE-35B4-4E20-806B-5ED98E8B943F Q34994815-D313CAFF-E647-4565-9D8E-025674A1AB9C Q35144197-758C9019-F04F-4DCC-8A1C-9C7FC5988F80 Q35244433-58C1F04D-B787-4242-8231-0415CD770F3F Q35676114-2101853B-4BED-4F9B-855D-5E6B64BB2F43 Q36039831-F74C9468-DF1C-4940-A419-E168E1BBFB94 Q36124883-1E0E6EAE-1C3E-465F-A7D6-8E28F2E35075 Q36346204-D5610394-99F2-4AD7-AD08-8DB1FCBBF85B Q36419132-BAA230C9-1564-4989-A72F-CC235DE2464D Q36584742-5F168366-D459-421B-B913-F58AF720C7AC Q36797979-E19E6427-D5DC-4EE5-BF2E-B41E402FB4E7 Q36907341-8C1A7D63-92FA-4921-8A47-51EF6628B7A5 Q36928846-CD17FE49-A617-4E9B-A8D3-8A529620CEA0 Q36945088-8BD43530-237A-4423-9691-5971CE317125 Q36998629-92BFD3D5-0DEC-4925-91AB-1D034EDB314A Q37167067-289244AC-9A7E-471E-A1EA-E0A7151D4ED5 Q37601809-D4BEFBF7-24CB-44A9-BBAA-618641842F2F Q37708177-CA4D6B0A-0685-414D-A55D-CE191BAC740A Q37950459-BA5BA3EC-83BF-4552-8E9D-F7B5C5923FA3 Q37972703-4F0D643F-ACBE-4D22-AE3D-185B64E09032 Q38044252-8F51ED91-7DAB-4E75-90EA-9BF34C9819EA Q38052458-5CCF83B3-AD3D-479D-BB1C-DDC45DE6EEAD Q38068114-520EF922-6314-4F0E-B415-E4C77910B1E9 Q38123202-A988CCD9-E0F7-418B-975F-AC8B8C27930E Q38125826-9E4929BB-DA4D-4868-A408-F1830AE2927D Q38163488-0C98E9C6-EB69-442D-B275-B521E05C0BF9 Q38178850-C1172644-6CBD-4FCD-AA23-DBF7D07A14D6 Q38262816-C1020479-0BD4-4EB3-B00A-56E399979F09 Q38268839-B81A6E18-4DB1-4978-9201-8A878C020401 Q38648768-535D7985-506F-4A5A-A916-F4950558238F Q39105991-E6F1437C-D7B6-418C-AAA5-678F93494870 Q39756478-18F7DFF8-2FF8-42C2-BAA0-47029111B8C6 Q40281409-4ABD0F11-2395-48C0-BD3F-5A612F85AC95 Q42056523-8AA6BD57-C47D-403E-A39A-764EC30CC482 Q43099200-4A92A192-9C01-44C8-B223-47937D7E65E7 Q44925816-0AFD563B-2978-4CEE-B1A3-9B8CCDAFB09E Q52624216-ACF70FD7-C641-4F74-B637-FB01DDCE570C

P2860

Critical review of prostate cancer predictive tools

http://www.wikidata.org/entity/Q34104562

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Critical review of prostate cancer predictive tools

@ast

Critical review of prostate cancer predictive tools

@en

Critical review of prostate cancer predictive tools

@nl

type

label

Critical review of prostate cancer predictive tools

@ast

Critical review of prostate cancer predictive tools

@en

Critical review of prostate cancer predictive tools

@nl

prefLabel

Critical review of prostate cancer predictive tools

@ast

Critical review of prostate cancer predictive tools

@en

Critical review of prostate cancer predictive tools

@nl

P1433

Q34104562-B6D20151-DFB5-4E91-AD21-A41F5A5619CD

P1476

Q34104562-15D89B41-CC48-4B1E-881F-7D1E8FEEA7B6

P2093

Q34104562-1B6571F2-A5B8-4EE9-B041-0B6FDDF73F9D

Q34104562-6B86DC99-76FE-4899-983E-980B42D4EC20

Q34104562-75F7C822-0A8C-4B2A-A290-C42C8F897BAB

Q34104562-EFF94DA3-1735-467A-B1EA-B6ACF8A59C90

P2860

Q34104562-01C08470-5EAA-4998-BEDF-A84C3F64CDBF

Q34104562-0321C6F3-2177-4652-A4F3-47C5AE060E9D

Q34104562-071D71EE-702B-4ECE-8D59-7E6E3B09F548

Q34104562-0806E3FC-FF32-40DF-8690-8302B3B7B6AC

Q34104562-0DA2A6C8-185B-44B0-AEE2-527070DF5840

Q34104562-116815E3-61F2-471B-98E9-6E141EEF944F

Q34104562-167D0EE4-DB7B-4B22-9DA4-C0BDF9542801

Q34104562-1721B117-F75B-46A6-B296-9515F42A63F7

Q34104562-1B540A03-DF75-4A7D-BCEE-4DF1C0F9B9B8

Q34104562-1BA2E1CC-1528-4B7D-9DBB-53E92DE04940

P304

Q34104562-9F393D63-C20F-4CF2-B551-E0E379F38BB5

P31

Q34104562-24AD4794-FA1D-4F1E-82BF-ED743E9AD05D

P356

Q34104562-19EF3A68-219A-41DC-B2EE-B64342A28F85

P407

Q34104562-269D1138-01ED-4DEC-AF11-5F4ABE45D992

P433

Q34104562-4D5ABF6A-F4F3-407E-88D3-27E647F82AEA

P478

Q34104562-F73E6DA2-1DAA-493D-8054-39B84766F78F

P50

Q34104562-2BD19B40-8D86-4103-89F7-3ED449D27E18

P577

Q34104562-1CE34A32-56A9-4E51-BBF7-8BB88AFB2A0E

P5875

Q34104562-9071EF71-D506-409E-8FA8-A4ECB2E6F97A

P698

Q34104562-2442C798-0A88-4980-87BE-69960135D02B

P932

Q34104562-8E867297-73CE-4763-996C-329C38269480

P356

P1433

Future Oncology

P1476

Critical review of prostate cancer predictive tools

@en

P2093

Michael W Kattan

http://www.w3.org/2001/XMLSchema#string

Peter T Scardino

http://www.w3.org/2001/XMLSchema#string

Pierre I Karakiewicz

http://www.w3.org/2001/XMLSchema#string

Shahrokh F Shariat

http://www.w3.org/2001/XMLSchema#string

P2860

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

Cancer statistics, 2009

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Natural history of progression after PSA elevation following radical prostatectomy.

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model.

Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy.

Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.

Decision curve analysis: a novel method for evaluating prediction models

Comparisons of nomograms and urologists' predictions in prostate cancer.

Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.

P304

1555-1584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.121

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J Vickers

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40679729

http://www.w3.org/2001/XMLSchema#string

P698

20001796

http://www.w3.org/2001/XMLSchema#string

P932

2933457

http://www.w3.org/2001/XMLSchema#string